Showing results (2711-2720 of 2,792) with videos related to
Sort By:
Pageof 280
Drugs & Aging|February 17, 2023
Implications of Under-Reporting Medication Side Effects: Beta-Blockers in Heart Failure as a Case ExampleFabian Vargas, Joanna Bryan Ringel, Brian Yum, et al.Drugs & Aging|May 8, 1998
Oesophageal mucosal diseases in the elderlyR Ouatu-Lascar, G TriadafilopoulosDrugs & Aging|April 20, 2023
Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective DatabaseGabriel Antherieu, Maël Heiblig, Gilles Freyer, et al.Drugs & Aging|January 10, 2026
Australian Polypharmacy Trends Between 2013 and 2024: A Repeated Cross-Sectional Study in the Adult PopulationGeorgie B Lee, Christopher Etherton-Beer, Julie A Pasco, et al.Drugs & Aging|April 18, 2020
An Analysis of Anesthesia Induction Dosing in Female Older AdultsEric Y Chen, George Michel, Bin Zhou, et al.Drugs & Aging|February 23, 2023
Inappropriate Combined Antiplatelet and Anticoagulant Therapy in Older Patients with Atrial Fibrillation: Trend over Time (2009-18)Emilie Philippe, Séverine Henrard, Benoit Boland, et al.Drugs & Aging|September 29, 2012
Age, dementia and care patterns after admission for acute coronary syndrome: an analysis from a nationwide cohort under the National Health Insurance coverageChen-Fang Lin, Fe-Lin Lin Wu, Shu-Wen Lin, et al.Drugs & Aging|September 29, 2012
Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort studySatabdi Chatterjee, Hua Chen, Michael L Johnson, et al.Drugs & Aging|September 29, 2012
Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patientsJeffrey Rado, Philip G JanicakDrugs & Aging|September 29, 2012
Assessment and management of pain, with particular emphasis on central neuropathic pain, in moderate to severe dementiaErik J A Scherder, Bart PlooijPageof 280